Meet Your Pediatric Medical Care Team

Amy Shapiro MD Amy Shapiro, M.D., serves as the CEO and Co-Medical Director of the IHTC. Dr. Shapiro is a board-certified Pediatric Hematologist-Oncologist, and received her medical degree in 1980 from the New York University School of Medicine. She completed her pediatric internship and residency and pediatric hematology/oncology fellowship at the University of Colorado Health Sciences Center. In 1987 she became an assistant professor of pediatrics at the Indiana University School of Medicine and the Medical Director of the Indiana Hemophilia Comprehensive Center. In 1993 she was promoted to associate professor with tenure. In July 1998 she founded the Indiana Hemophilia and Thrombosis Center (IHTC) as an independent program with Dr. Anne Greist. Dr. Shapiro is head of pediatric services at the IHTC. She is also an Adjunct Professor of Pediatrics at Michigan State University. Dr. Shapiro has served on the Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation since April 1997, and is active in many local, regional, national, and international medical organizations. Dr. Shapiro was Chair of the American Thrombosis and Hemostasis Network (ATHN) Board of Directors in 2008, and continues to be active on the board. Dr. Shapiro is a member of the International Society on Thrombosis and Haemostasis since 1991. Dr. Shapiro currently serves on several of the National Institutes of Health Boards. In 1997 she was honored with the “Tony and Mary Hulman Health Achievement Award” and in 1998 with the “W. George Pinnell Award” for Outstanding Service from Indiana University. She was named “Physician of the Year” in 2001 by the National Hemophilia Foundation and received the “Distinguished Hoosier Award” in 2009 from the State of Indiana, presented to her by Governor Mitch Daniels. She has also authored or co-authored over 120 articles and abstracts and eight textbook chapters. Click here to see this IHTC physician’s research articles and publications since 2010.
Sweta Gupta MD Sweta Gupta, M.D., serves as an IHTC Pediatric Hematologist. Dr. Gupta attended medical school at Maharaja Sayaji Rao University in India. Dr. Gupta completed her Pediatric Residency at OSF St. Francis Medical Center in Peoria, Illinois, and her Pediatric Hematology/Oncology Fellowship at the Medical College of Wisconsin in Milwaukee. Dr. Gupta has a special interest in Von Willebrand disease (VWD) including diagnosis, management and impact on quality of life. Dr. Gupta has co-authored several papers in journals including Haemophilia and Pediatric Hematology/Oncology. Dr. Gupta works within the IHTC to improve service delivery to bleeding disorder patients, including improved pre-natal counseling and care to newborns and infants. Dr. Gupta is an investigator for a study to validate the composite score to identify VWD in children. Dr. Gupta enjoys painting, cooking and spending time with her family. Click here to see this IHTC physician’s research articles and publications since 2010.
Charles Nakar MD Charles Nakar, M.D., serves as an IHTC Pediatric Hematologist. Dr. Nakar attended medical school at Ben-Gurion University in Israel. Dr. Nakar completed his Pediatric Residency at Ben-Gurion University and the North Shore-Long Island Jewish System/Schneider Children’s Hospital Program. Dr. Nakar completed his Pediatric Hematology/Oncology fellowship at Cornell University and Memorial Sloan Kettering Cancer Center in New York. Dr. Nakar has a special interest in hemophilia, specifically surgical interventions, management and outcomes, inhibitor development and eradication, and intracranial hemorrhage (ICH). Dr. Nakar also has expertise in platelet pathophysiology, genetic disorders, and ITP. In 2010 Dr. Nakar published a paper in Haemophilia analyzing the safety and efficacy of recombinant activated factor VII in the treatment of ICH in hemophilia patients with inhibitors. Dr. Nakar works within the IHTC to improve service delivery to bleeding disorder patients, including improved pre-natal counseling and care to newborns and infants. Dr. Nakar is overseeing the development of a unified problem list for all IHTC patients to further improve continuity of care. He is also overseeing analysis of the IHTC surgical database to ensure optimal hemostasis for patients with bleeding disorders at the time of a procedure. Dr. Nakar enjoys photography and stamp collecting. Click here to see this IHTC physician’s research articles and publications since 2010.
Angeli Rampersad MD Angeli Rampersad, M.D., serves as an IHTC Pediatric Hematologist. Dr. Rampersad attended medical school at the University of the West Indies in Trinidad. Dr. Rampersad earned her Doctorate of Medicine and Surgery and served as house staff at the University of the West Indies, Department of Pediatrics. She completed her Pediatric Residency and served as Chief Resident at the State University of New York – Downstate Medical Center in Brooklyn. Dr. Rampersad completed her Pediatric Hematology/Oncology fellowship at Cornell University and Memorial Sloan Kettering Cancer Center. Dr. Rampersad has a special interest in bleeding disorders and hemoglobin disorders. She is the Director of the Indiana Sickle SAFE Newborn Screening Program, Indiana’s only newborn screening program for sickle cell disease providing screening, assessment, follow-up and educational services for infants with sickle cell disease and their families. Dr. Rampersad has authored a manuscript focused on the use of radiosynovectomy as a treatment for hemophilic synovitis based on the experiences of two hemophilia treatment centers – the IHTC and La Paz University Hospital in Spain. Dr. Rampersad enjoys reading fiction, dining out, traveling and spending time with her family. Click here to see this IHTC physician’s research articles and publications since 2010.
Nihal Bakeer MD Nihal Bakeer, M.D., serves as an IHTC Pediatric Hematologist. Dr. Bakeer attended medical school at the University of Jordan in Amman, Jordan. She completed her residency in Pediatric and Adolescent Medicine and her fellowship in Pediatric Hematology/Oncology at Cincinnati Children’s Hospital Medical Center. Dr. Bakeer has a special interest in thrombosis including complex anticoagulation management in patients with artificial heart devices or those on extracorporeal membrane oxygenation (ECMO). Dr. Bakeer is also interested in other benign hematologic disorders including bleeding disorders; Dr. Bakeer leads the IHTC’s point of care joint ultrasound project for patients with hemophilia. In her spare time, Dr. Bakeer enjoys hiking, indoor rock climbing, cooking and drawing.
Emily Meier MD Emily Meier, M.D., serves as an IHTC Pediatric Hematologist and the Director of Sickle Cell Research. Dr. Meier attended medical school at the Indiana University School of Medicine. Dr. Meier completed her Pediatric Residency, Chief Residency and Hematology/Oncology Fellowship at Children’s National Medical Center in Washington, DC. Dr. Meier has a special interest in sickle cell disease and other benign hematologic disorders. Dr. Meier has co-authored papers in journals including The New England Journal of Medicine and American Journal of Hematology. She is involved with the Sickle SAFE program and STORM project, both of which work to improve access to and quality of medical care to those with sickle cell disease in Indiana and the region. Dr. Meier enjoys reading, swimming, playing card games and spending time with her family.
Manjusha Kumar MD Manjusha Kumar, M.D., serves as an IHTC Pediatric Hematologist. Dr. Kumar attended medical school at All India Institute of Medical Sciences in New Delhi, India. She completed her Pediatric Residency at the Post Graduate Institute of Medical Education and Research in Chandigarh, India and her Pediatric Hematology/Oncology Fellowships at the University of British Columbia Vancouver in Canada and the University of Florida, College of Medicine in Gainesville, Florida. She has a special interest in childhood immune thrombocytopenia, vascular anomalies, sickle cell disease, and hereditary spherocytosis. Dr. Kumar is working to develop a vascular anomalies center at the IHTC. She has over 20 years’ experience in hematology. In her free time, Dr. Kumar enjoys watching her sons play college tennis. She also plays tennis herself, frequently reads and travels.
Did you like this? Share it: